Isofol Medical AB (publ) (OM: ISOFOL)
Health Care · Biotechnology · SE
Skr0.83
+3.51% today · +14.7% 1Y
Isofol Medical AB (publ) (OM: ISOFOL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $26.73M and employs 7 people.
Over the last twelve months the share price has gained 14.7%, trading between 0.55 and 0.99.
Tweenvest scores Isofol Medical AB (publ) across four factors: quality 35/100, value 60/100. Its strongest factor is value.
ISOFOL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $26.73M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- 1.02
- 52-week high
- Skr0.99
- 52-week low
- Skr0.55
- Avg volume (3M)
- —
- Shares outstanding
- 320.49M
- Employees
- 7
- Next earnings
- —
About Isofol Medical AB (publ)
Isofol Medical AB (publ) is a clinical-stage biotechnology firm dedicated to the research, marketing, and global distribution of oncology medications, with operations both in Sweden and abroad. Its leading therapeutic candidate, arfolitixorin, is presently undergoing Phase 3 clinical trials for individuals with advanced colorectal cancer. The company has forged significant strategic alliances with organizations including Recipharm, Merck & Cie, and Sahlgrenska University Hospital. Established in 2008, its corporate base is situated in Gothenburg, Sweden.
- ISIN
- SE0009581051
- Founded
- 2008
- Listed since
- Apr 4, 2017
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chordia Therapeutics Inc.TSE: 190A | $27.40M | ¥56.00 | -1.75% |
| IMB Dx, Inc.KOSDAQ: A461030 | $27.39M | ₩2,605.00 | -8.44% |
| LabGenomics Co., Ltd.KOSDAQ: A084650 | $27.17M | ₩2,440.00 | -12.07% |
| Atossa Therapeutics, Inc.NasdaqCM: ATOS | $27.14M | $2.72 | +7.51% |
| Kim Forest Enterprise Co., Ltd.TWSE: 6645 | $26.71M | NT$14.35 | +6.30% |
| Noile-Immune Biotech Inc.TSE: 4893 | $25.84M | ¥94.00 | -7.84% |
| Seoulin Bioscience Co.,Ltd.KOSDAQ: A038070 | $25.81M | ₩3,810.00 | -6.39% |
| Genesystem Co., Ltd.KOSDAQ: A363250 | $25.76M | ₩4,145.00 | +1.97% |
Figures last refreshed Oct 18, 2026.